Susan McLaughlin
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Co-authors
- André Rogatko (4 shared papers)Susan Hunter (1 shared paper)Paul Sabatier (1 shared paper)Mary Beard (6 shared papers)Margaret von Mehren (3 shared papers)Louis M. Weiner (4 shared papers)Jeffrey Schlom (2 shared papers)Harry S. Cooper (2 shared papers)
- Journals
- BMC Cancer (2 papers)Journal of Clinical Oncology (2 papers)Scientific Reports (1 paper)The Diabetes Educator (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Susan McLaughlin
26 papers receiving 677 citations
Peers
Comparison fields: 5 of 98
- Oncology 317
- Immunology 237
- Finance 96
- Public Administration 30
- Biotechnology 38
Countries citing papers authored by Susan McLaughlin
This map shows the geographic impact of Susan McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan McLaughlin more than expected).
Fields of papers citing papers by Susan McLaughlin
This network shows the impact of papers produced by Susan McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan McLaughlin. The network helps show where Susan McLaughlin may publish in the future.
Co-authors
The 25 scholars most cited alongside Susan McLaughlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. | 2001 | 138 |
| 2 | 2003 | 135 | |
| 3 | Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. | 2000 | 124 |
| 4 | 1987 | 86 | |
| 5 | Key Mechanics of the U.S. Tri-Party Repo Market | 2012 | 52 |
| 6 | 2006 | 29 | |
| 7 | 2004 | 28 | |
| 8 | 2009 | 21 | |
| 9 | The Impact of Interstate Banking and Branching Reform: Evidence from the States | 1995 | 15 |
| 10 | 2013 | 13 | |
| 11 | 2008 | 12 | |
| 12 | 2009 | 10 | |
| 13 | Foreign Exchange Liquidity in the Americas | 2017 | 7 |
| 14 | 2010 | 7 | |
| 15 | Explaining the U.S. tri-party repo market | 2012 | 6 |
| 16 | Policy Issues in the Design of Tri-Party Repo Markets | 2011 | 5 |
| 17 | 2015 | 4 | |
| 18 | 2025 | 3 | |
| 19 | 1996 | 3 | |
| 20 | 2025 | 2 |
About Susan McLaughlin
Susan McLaughlin is a scholar working on Finance, Oncology, Molecular Biology, Surgery and Public Health, Environmental and Occupational Health, having authored 33 papers that have together received 707 indexed citations. Recurring topics across this work include Banking stability, regulation, efficiency (9 papers), Credit Risk and Financial Regulations (3 papers), Financial Markets and Investment Strategies (2 papers), Diabetes Management and Education (2 papers), CAR-T cell therapy research (2 papers), Corporate Finance and Governance (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Family Support in Illness (2 papers). The work is most often cited by research in Oncology (317 citations), Immunology (237 citations), Finance (96 citations), Public Administration (30 citations) and Biotechnology (38 citations). Susan McLaughlin has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include André Rogatko, Susan Hunter, Paul Sabatier, Mary Beard, Margaret von Mehren, Louis M. Weiner, Jeffrey Schlom, Harry S. Cooper, Philip M. Arlen and Antoine Martin. Their work appears in journals such as BMC Cancer, Journal of Clinical Oncology, Scientific Reports, The Diabetes Educator and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.